NL-OMON24732已完成不适用
The role of gut microbiota in CHOline and CARnitine metabolism on vascular inflammation in metabolic syndrome; the ChoCar-trial
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- AMC
- 入组人数
- 50
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •patients: treatment naive male obese patients with metabolic syndrome; 21 to 69 years-old; body mass index (BMI) 30 to 43 kg/m2
排除标准
- •patients: Supplement use (including vitamin/choline/carnitine supplements, energy drinks and carnitine-enriched soymilk) is not allowed. Other exclusion criteria are a medical history of a cardiovascular event (myocardial infarction/stroke), cholecystectomy, use of medication including antacids and oral antibiotics in the past three months and immunodeficiency.
研究者
相似试验
已完成
不适用
ChoCar trial; The role of gut microbiota in choline and carnitine metabolism on vascular inflammation in metabolic syndromevessel calcification1001108210003216AtherosclerosisNL-OMON39717Academisch Medisch Centrum40
已完成
不适用
An Intervention on Healthy Adults of Probiotics on Gut Flora Metabolisms of CholineHealthyNCT03292978Huilian Zhu40
已完成
不适用
Choline Source, Gut Microbiota and Trimethylamine-N-oxide ResponseMetabolismNCT04255368Utah State University44
已完成
早期 1 期
Gut Flora Dependent Metabolism of Dietary Phosphatidylcholine and Cardiovascular DiseaseNutritionNCT01519310The Cleveland Clinic4
进行中（未招募）
1 期
Gut microbiota, PGx and INSTIs responseEUCTR2020-001103-17-BECliniques universitaires Saint-Luc200